BIOTIE THERAPIES CORP.
Patent Applications and Registrations
Patent applications and USPTO patent grants for BIOTIE THERAPIES CORP..The latest application filed is for "use of vap-1 inhibitors for treating fibrotic conditions".
- BIOTIE THERAPIES CORP. - Turku N/A FI
- BIOTIE THERAPIES CORPORATION - Turku FI
- Biotie Therapies Corp. - Turkku FI
- Biotie Therapies Corporation -
- BioTie Therapies Corp. - Turku Technology Center BioCity Tykistokatu 6 Turku FI
- Biotie Therapies, Corp. - FI FI
Trademarks
| Patent | Date |
|---|---|
| Use of VAP-1 inhibitors for treating fibrotic conditions Grant 10,576,148 - Weston , et al. | 2020-03-03 |
| Pyridazinone and pyridone compounds Grant 10,479,771 - Pihlavisto , et al. Nov | 2019-11-19 |
| Use Of Vap-1 Inhibitors For Treating Fibrotic Conditions App 20180071388 - WESTON; Christopher ; et al. | 2018-03-15 |
| Pyridazinone And Pyridone Compounds App 20180029995 - PIHLAVISTO; Marjo ; et al. | 2018-02-01 |
| Pyridazinone and pyridone compounds Grant 9,815,795 - Pihlavisto , et al. November 14, 2 | 2017-11-14 |
| Use of VAP-1 inhibitors for treating fibrotic conditions Grant 9,795,671 - Weston , et al. October 24, 2 | 2017-10-24 |
| Pyridazinone And Pyridone Compounds App 20160244414 - PIHLAVISTO; Marjo ; et al. | 2016-08-25 |
| Pyridazinone compounds Grant 9,371,290 - Pihlavisto , et al. June 21, 2 | 2016-06-21 |
| Nalmefene hydrochloride dihydrate Grant 8,754,217 - Lopez de Diego , et al. June 17, 2 | 2014-06-17 |
| New Pyridazinone And Pyridone Compounds App 20140024648 - Pihlavisto; Marjo ; et al. | 2014-01-23 |
| Nalmefene Hydrochloride Dihydrate App 20130338365 - Lopez de DIEGO; Heidi ; et al. | 2013-12-19 |
| Urea Substituted Sulphonamide Derivatives App 20120196884 - Koivunen; Jarkko Tapani ; et al. | 2012-08-02 |
| Compositions Useful Especially For Treatment Or Prevention Of Metabolic Syndrome App 20120115815 - JALKANEN; Sirpa ; et al. | 2012-05-10 |
| Methods of treating an inflammatory condition involving VAP-1-mediated adhesion with VAP-1-specific antibodies Grant 8,142,783 - Smith , et al. March 27, 2 | 2012-03-27 |
| Compositions useful especially for treatment or prevention of metabolic syndrome Grant 8,119,651 - Jalkanen , et al. February 21, 2 | 2012-02-21 |
| Nalmefene Hydrochloride Dihydrate App 20110251228 - Lopez de Diego; Heidi ; et al. | 2011-10-13 |
| Fully human anti-VAP-1 monoclonal antibodies Grant 7,897,149 - Smith , et al. March 1, 2 | 2011-03-01 |
| Glucuronyl C5-Epimerase, DNA encoding the same and uses thereof App 20100261253 - Jalkanen; Markku ; et al. | 2010-10-14 |
| Collagen Receptor I-Domain Binding Modulators App 20090286713 - Heino; Jyrki ; et al. | 2009-11-19 |
| Novel fully human anti-VAP-1 monoclonal antibodies App 20090081126 - Smith; David John ; et al. | 2009-03-26 |
| Crystalline VAP-1 and uses thereof Grant 7,499,847 - Salminen , et al. March 3, 2 | 2009-03-03 |
| Collagen Receptor I-Domain Binding Modulators App 20080255028 - Heino; Jyrki ; et al. | 2008-10-16 |
| Glucuronyl C5-epimerase, DNA encoding the same and uses thereof Grant 7,399,626 - Jalkanen , et al. July 15, 2 | 2008-07-15 |
| Carbocyclic hydrazino inhibitors of copper-containing amine oxidases Grant 6,982,286 - Smith , et al. January 3, 2 | 2006-01-03 |
| Glucuronyl C5-epimerase, DNA encoding the same and uses thereof App 20050181434 - Jalkanen, Markku ; et al. | 2005-08-18 |
| Glucuronyl C5-epimerase, DNA encoding the same and uses thereof Grant 6,887,698 - Jalkanen , et al. May 3, 2 | 2005-05-03 |
| DNA sequence encoding a novel glucuronyl C5-epimerase Grant 6,764,844 - Lindahl , et al. July 20, 2 | 2004-07-20 |
| Inhibitors of copper-containing amine oxidases Grant 6,624,202 - Smith , et al. September 23, 2 | 2003-09-23 |
| Carbocyclic hydrazino inhibitors of copper-containing amine oxidases App 20030125360 - Smith, David John ; et al. | 2003-07-03 |
| Inhibitors of copper-containing amine oxidases App 20020173521 - Smith, David John ; et al. | 2002-11-21 |
| Glucuronyl C5-epimerase, DNA encoding the same and uses thereof App 20020127696 - Jalkanen, Markku ; et al. | 2002-09-12 |
| SEC | 0001579695 | Biotie Therapies Corp. of FINLAND |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 